what drug is tirzepatide (Mounjaro): Type 2 Diabetes Guide Use of the dual GIP/GLP-1

Common side effects when restarting include: Nausea and vomiting (affecting approximately 15-20% of patients according to the SmPC) [1] [4] Diarrhoea or constipation Abdominal discomfort or bloating Reduced appetite (which may be more pronounced if you're still recovering nutritionally) Fatigue or general malaise Injection site reactions (redness, itching, or mild swelling) These effects are generally mild to moderate and self-limiting , resolving within days to a few weeks

Chen Z, Liu XA, Kenny PJ

These lifestyle changes can often make a significant difference and might reduce the need for laxatives altogether

patients should report right upper quadrant pain promptly Pancreatitis: Severe, persistent abdominal pain warrants immediate medical evaluation